IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly

Growth Hormone and IGF Research

Volumn 20, Issue 6, 2010, Pages 399-403

  Akin, Fulya ^a   Turgut, Sebahat ^a   Cirak, Bayram ^a   Kursunluoglu, Raziye ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Acromegaly; IGF 1 gene polymorphism; IGFBP 3 gene polymorphism

Indexed keywords

ALANINE; CHOLESTEROL; CYSTEINE; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ACROMEGALY; ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROMOTER REGION; TRIACYLGLYCEROL BLOOD LEVEL;

ACROMEGALY; ADULT; AGED; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; DRUG RESISTANCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 78649635938     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.09.001     Document Type: Article

References (24)

1. Melmed S. Acromegaly. N Engl J. Med. 1990, 322:966-977.
2. Colao A., Lombardi G. Growth-hormone and prolactin excess. Lancet 1998, 352:1455-1461.
3. Orme S.M., McNally R.J., Cartwright R.A., Belchetz P.E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J. Clin. Endocrinol. Metab. 1998, 83:2730-2734.
4. Colao A., Ferone D., Marzullo P., Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 2004, 25:102-152.
5. Holdaway I.M., Rajasoorya R.C., Gamble G.D. Factors influencing mortality in acromegaly. J. Clin. Endocrinol. Metab. 2004, 89:667-674.
6. Ferns G.A., Motani A.S., Anggard E.E. The insulin-like growth factors: their putative role in atherogenesis. Artery 1991, 18(4):197-225.
7. Janssen J.A., Stolk R.P., Pols H.A. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb. Vasc. Biol. 1998, 18(2):277-282.
8. Bayes-Genis A., Conover C.A., Schwartz R.S. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ. Res. 2000, 86(2):125-130.
9. Frayling T.M., Hattersley A.T., McCarthy A., Holly J., Mitchell S.M., Gloyn A.L., Owen K., Davies D., Smith G.D., Ben-Shlomo Y. A putative functional polymorphism in the IGF-I gene-association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes 2002, 51:2313-2316.
10. Vaessen N., Heutink P., Janssen J.A., Witteman J.C., Testers L., Hofman A., Lamberts S.W., Oostra B.A., Pols H.A., van Duijn C.M. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001, 50:637-642.
11. Rietveld I., Janssen J.A., van Rossum E.F., Houwing-Duistermaat J.J., Rivadeneira F., Hofman A., Pols H.A., van Duijn C.M., Lamberts S.W. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin. Endocrinol. (Oxf) 2004, 61:195-203.
12. Schut A.F., Janssen J.A., Deinum J., et al. Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 2003, 34(7):1623-1627.
13. Rasmussen S.K., Lautier C., Hansen L., Echwald S.M., Hansen T., Ekstrøm C.T., Urhammer S.A., Borch-Johnsen K., Grigorescu F., Smith R.J., Pedersen O. Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2000, 85:1606-1610.
14. Paquette J., Bessette B., Ledru E., Deal C. Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin. Endocrinology 2007, 148:6007-6018.
15. Ali O., Cohen P., Lee K.W. Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule. Horm. Metab. Res. 2003, 35:726-733.
16. Deal C., Ma J., Wilkin F., Paquette J., Rozen F., Ge B., Hudson T., Stampfer M., Pollak M. Novel promoter polymorphism in insulin-like growth factor binding protein-3: correlation with serum levels and interaction with known regulators. J. Clin. Endocrinol. Metab. 2001, 86:1274-1280.
17. Jernstrom H., Deal C., Wilkin F., Chu W., Tao Y., Majeed N., Hudson T., Narod S.A., Pollak M. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in healthy premenopausal women. Cancer Epidemiol. Biomarkers Prev. 2001, 10:377-384.
18. Freda P.U. Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm. IGF Res. 2003, 13:171-184.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Schildkraut J.M., Wahnefried W.D., Wenham R.M., Grubber J., Jeffreys A.S., Grambow S.C., Marks J.R., Moorman P.G., Hoyo C., Ali S., Walther P.J. IGF1 (CA)19 repeat and IGFBP3-202 A/C genotypes and the risk of prostate cancer in black and white men. Cancer Epidemiol. Biomarkers Prev. 2005, 14(2):403-408.
21. Allen N.E., Davey G.K., Key T.J., Zhang S., Narod S.A. Serum insulin like growth factor I (IGF-I) concentration in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene. Cancer Epidemiol. Biomarkers Prev. 2002, 11:319-320.
22. Yu H., Li B.D., Smith M., Shi R., Berkel H.J., Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res. Treat. 2001, 70:117-122.
23. Missmer S.A., Haiman C.A., Hunter D.J., Willett W.C., Colditz G.A., Speizer F.E., Pollak M.N., Hankinson S.E. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int. J. Cancer 2002, 100:332-336.
24. Filopanti M., Ronchi C., Ballare E., Bondioni S., Lania A.G., Losa M., Gelmini S., Peri A., Orlando C., Beck-Peccoz P., Spada A. Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly. J. Clin. Endocrinol. Metab. 2005, 90:4824-4828.